Marina Biotech, Inc. 4
4 · Marina Biotech, Inc. · Filed Jul 5, 2017
Insider Transaction Report
Form 4
Hwang Larn
Chief Scientific Officer
Transactions
- Award
5% Convertible Promissory Note
2017-06-30$50000.00/sh→ 142,857 totalExercise: $0.35From: 2018-06-01→ common stock (142,857 underlying)
Footnotes (2)
- [F1]The holders of a majority of the aggregate principal amount of the convertible promissory notes that were issued by the registrant in the offering of which the note purchased by the reporting person is a part have the right to elect to convert the entire unpaid principal amount (and accrued interest) of such notes into the common stock of the registrant on the maturity date of such notes.
- [F2]N/A